Success Story: Only 2 Months to NIW Approved for an Egyptian Medical Under Premium Processing Requested With Our Strategic Filing
Client’s Testimonial:
“I am pleased with the experience with Chen group immigration. The lawyers are well organized and very professional. Communication has been seamless during the process of the petition with clear guidance. Overall highly recommended.”
On February 12th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Medical Oncologist in the field of Cancer Research and Precision Oncology (Approval Notice).
General Field: Cancer Research and Precision Oncology
Position at the Time of Case Filing: Medical Oncologist
Country of Origin: Egypt
State of Residence at the Time of Filing: Kansas
Approval Notice Date: February 12th, 2026
Processing Time: 2 months (Premium Processing Requested)
Case Summary:
This NIW approval highlights an Egyptian medical oncologist whose work combines cancer research and precision oncology. The proposed endeavor focuses on analyzing germline variants as well as genetic and molecular biomarkers that enable the earlier detection of gastrointestinal cancers, improve risk assessments for patients and their families, and guide targeted treatments for gastrointestinal malignancies in the United States. At the time of filing, the client was continuing this work through a medical oncology position aligned with the proposed endeavor.
Research with National Importance
In the petition, we demonstrated substantial merit and national importance by linking the endeavor to U.S. needs in addressing one of the leading causes of death nationwide. We highlighted that incidences of gastrointestinal cancers, especially those of the gastric cardia, colorectum, liver, and pancreas. The client's work uniquely contributes to efforts aimed at combating this critical public health issue by identifying cancer-related germline mutations, improving cancer diagnostics, and minimizing ineffective and costly treatments.
Academic Contributions and Recognition
The petition documented an established record of scholarly output and peer trust. The client's work includes 23 peer-reviewed journal articles (10 of them first-authored), 34 abstracts (9 of them first-authored), and 1 book chapter. The work has received 186 citations, reflecting meaningful reliance by other researchers. Remarkably, multiple papers rank among the most highly cited in their respective publication years. These outstanding citation percentiles clearly demonstrate the major impact of the client's original contributions. The petition also documented at least 10 completed peer reviews for respected journals
NIW Approval and Outlook
The I-140 NIW petition was achieving remarkably swift approval in just 2 months under premium processing without any Request for Evidence. In the filing, we showed that the endeavor has substantial merit and national importance, the client is well-positioned to advance it through a strong publication, citation, and peer-recognition record, and that granting the waiver benefits the United States by enabling continued progress in precision oncology for gastrointestinal cancer detection and treatment.